ROYAL BANK OF CANADA
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1000275
TORONTO, A6
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$271,328,756
+$4,864,571 QoQ
Shares Held
351,171
+1.7% QoQ
Ownership
0.335%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.69786799023838.ToString("F0")%
Shared 0.1073551062018219.ToString("F0")%
None 0.19477690355980418.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Mar 31, 2026CallValue
$13,598,464
CallShares
17,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $1,974,349,900 across 410 Biotechnology names. REGN ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,111,871 | $496,494,870 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
3,801,815 | $285,478,282 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
351,171 | $271,328,756 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
791,515 | $261,888,563 | |
| 5 | INCY |
Incyte Corp
|
1,054,123 | $99,214,053 | |
| 6 | INSM |
INSMED Inc
|
523,101 | $85,537,473 | |
| 7 | MRNA |
Moderna, Inc.
|
999,340 | $50,766,470 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
658,290 | $42,545,279 |
All Filings in REGN
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,598,464 | 17,600 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $271,328,756 | 351,171 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $266,464,185 | 345,219 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $209,780,120 | 373,095 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $202,061,475 | 384,879 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $128,873,628 | 203,197 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $205,818,489 | 288,937 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $274,836,181 | 261,440 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $209,098,210 | 198,946 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $133,356,834 | 138,554 | Shares | Defined | 2024-11-05 | |
| 2024-03-31 | $192,498 | 200 | Put | Defined | 2024-11-05 | |
| 2023-12-31 | $229,928,411 | 261,791 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $131,618,457 | 159,933 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $109,894,941 | 152,942 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $148,578,473 | 180,825 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $4,519,185 | 5,500 | Put | Sole | 2023-05-15 | |
| 2022-12-31 | $215,042,976 | 298,054 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $222,883,195 | 323,549 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $198,987,949 | 336,623 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $219,550,416 | 314,353 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $175,637,704 | 278,119 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $119,194,434 | 196,957 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $56,318,141 | 100,831 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $48,239,457 | 101,956 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $79,872,571 | 165,330 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $67,521,779 | 120,622 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $67,483,291 | 108,207 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $40,208,235 | 82,345 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||